Navigation Links
Report focuses on challenges to unlocking future promise of vaccines

Vaccines have helped eradicate and tame some of history's worst infectious diseases, but there are many more diseases out there that vaccines can help overcome. The challenges society needs to confront to unlock the future promise of vaccines against the plagues of the 21st century are the focus of a new report by the American Academy of Microbiology.

"The success of vaccines in controlling disease has been profound. Many diseases that formerly raged unchecked are now under control and others have been eliminated in parts of the world. Despite this success, infectious diseases continue to be public health problems particularly in developing countries where vaccines are unavailable, unaffordable, or both," says James Kaper of the University of Maryland School of Medicine, co-author of the report, Vaccine Development: Current Status and Future Needs.

The report is the outcome of a colloquium convened by the Academy in March 2005 to discuss vaccines, current infectious disease problems, the potential for new and better vaccines, vaccine safety, research issues surrounding vaccines, education, and training topics. Experts in vaccine research and development from academia, industry, and government deliberated and determined several recommendations for future progress in creating and applying vaccines.

The report identifies over 40 infectious agents that pose significant human health problems in the United States or abroad, the most significant of which is HIV. Of the infectious agents identified, only 12 currently have effective vaccines. In addition, the report also identifies a number of infectious agents that are relatively rare today, but are poised to emerge by either natural or terrorism-related means, like avian influenza, West Nile virus, and botulism toxin.

According to the report, research and development must continue the progress of the past to address those diseases that have eluded the development of effective va
'"/>

Source:American Society for Microbiology


Page: 1 2

Related biology news :

1. Report that delayed motherhood decreases life expectancy of mouse offspring
2. AIDS Public Awareness Campaign Expands Following Report Of Rapidly Progressive HIV
3. Report finds cruise industry is protecting the precious places it visits
4. Report shows deforestation threatens Brazils Pantanal
5. Report lists top 20 most-vulnerable African carnivores
6. Report focuses on the role good microbes play in future medicine
7. Report warns about carbon dioxide threats to marine life
8. Report highlights change in Canadas forests
9. Report calls for improved monoclonal antibodies against solid tumors
10. Study of energy and health in Africa focuses spotlight on charcoal and forest management
11. Changing ecosystems throw scientists mega-challenges
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Report focuses challenges unlocking future promise vaccines

(Date:7/11/2014)... available in German . ... that uses the refraction of X-rays through a specimen ... with this method are often of much higher quality ... team of Prof. Franz Pfeiffer are particularly interested in ... including X-ray phase-contrast imaging. One main goal is ...
(Date:7/11/2014)... Salk Institute for Biological Studies, BGI, and other ... and reliability of the existing targeted gene correction ... which could significantly increased gene-correction efficiency in human ... online in Cell Stell Cell provides ... therapy. , The combination of stem cells and ...
(Date:7/11/2014)... Researchers have pioneered a revolutionary new way to ... Virtual Finger, allows scientists to move through digital ... using the flat surface of their computer screens. ... orders of magnitude more efficient, saving time, money ... areas of experimental biology. The software and its ...
Breaking Biology News(10 mins):New simple setup for X-ray phase contrast 2A new genome editing method brings the possibility of gene therapies closer to reality 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
... accumulation of genetic damage in our cells is a major ... published today in the journal Nature by an international group ... critical gene for repairing damaged DNA grow old rapidly and ... that grow old naturally. Furthermore, the premature aging symptoms of ...
... transplant (HSCT) recipients face a significant long-term risk for ... at the time of transplant or received stem cells ... Published in the January 1, 2007 issue of CANCER ... Cancer Society, the study reveals that within 10 years ...
... researchers have developed a biochip that measures the electrical activities ... data in just one reading than is possible with current ... speed scientific research, which could accelerate drug development for muscle ... crop varieties. , "Instead of doing one experiment ...
Cached Biology News:Buildup of damaged DNA in cells drives aging 2Buildup of damaged DNA in cells drives aging 3Buildup of damaged DNA in cells drives aging 4Long-term cancer risk follows stem cell transplant recipients 2New biochip helps study living cells, may speed drug development 2New biochip helps study living cells, may speed drug development 3
(Date:7/11/2014)... BCC Research ( http://www.bccresearch.com ) reveals ... REACTION (PCR) TECHNOLOGY: GLOBAL MARKETS , the global market ... $140 billion in 2013. This is estimated to grow ... annual growth rate (CAGR) of 28.6%. , New digital ... exciting possibilities within the broader PCR field. The opportunities ...
(Date:7/11/2014)... 11, 2014 /CNW/ - Sunovion Pharmaceuticals Canada Inc. (Sunovion) ... (eslicarbazepine acetate) for use as a once-daily adjunctive therapy ... epilepsy who are not satisfactorily controlled with conventional therapy. ... patients under 18 years of age. ... and according to Epilepsy Canada, it affects 0.6% of ...
(Date:7/11/2014)... July 11, 2014 Cayenne Medical, ... specializing in the soft tissue reconstruction segment, announced ... System for surgeries involving the shoulder and extremities. ... a novel, inserter-controlled deployment method. The unique delivery ... deployment, anchor pull-out, or anchor displacement (also commonly ...
(Date:7/10/2014)... Product and process impurities in biopharmaceuticals ... are often “lost in the noise,” making their ... Dr. Rowel Tobias, Senior Scientist, Protein Chemistry at ... Quality at Nanotherapeutics, Inc., to lear about a ... and quantitation while achieving the required specificity and ...
Breaking Biology Technology:Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 2Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 3Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2
... among stations to run 30-second spot on Pyratine XR(TM) and ... Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company ... of healthy aging, announced today that on June 27, 2009 ... XR(TM) (0.125% furfuryl tetrahydropyranyl adenine) and rosacea, a condition afflicting ...
... N.C., June 26 Syngenta Biotechnology, Inc. announced today ... and commercial license agreement for Chromatin,s proprietary gene stacking ... Chromatin has developed a novel approach to gene stacking, ... Under this agreement, Syngenta has obtained exclusive rights to ...
... EasyMax™ is a ... heating and cooling without an additional cryostat. For a limited time, METTLER TOLEDO is ... EasyMax™, and the chance to WIN A SKI WEEKEND* in St. Moritz, Switzerland or Colorado, ... Columbia, MD (PRWEB) ...
Cached Biology Technology:Television News Segment Featuring Pyratine XR to Air to 18 Million + Households on DIRECTV NewsCluster 2Syngenta Licenses Chromatin Gene Stacking Technology for Sugar Cane 2Syngenta Licenses Chromatin Gene Stacking Technology for Sugar Cane 3Register to Win a Ski Weekend and Make Your Synthesis Easier with EasyMax™: the First Automated Chemistry Development Tool That Requires No Training 2
Mouse monoclonal antibody raised against a partial recombinant COG2. NCBI Entrez Gene ID = COG2...
Mouse polyclonal antibody raised against a partial recombinant AGTRAP. NCBI Entrez Gene ID = 57085...
Mouse polyclonal antibody raised against a partial recombinant NCLN. NCBI Entrez Gene ID = 56926...
...
Biology Products: